310 related articles for article (PubMed ID: 33525365)
1. Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges.
Doultsinos D; Mills IG
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33525365
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Regulation in Prostate Cancer Progression.
Ruggero K; Farran-Matas S; Martinez-Tebar A; Aytes A
Curr Mol Biol Rep; 2018; 4(2):101-115. PubMed ID: 29888169
[TBL] [Abstract][Full Text] [Related]
3. Transcription Factors as Novel Therapeutic Targets and Drivers of Prostate Cancer Progression.
Xie K; Tan K; Naylor MJ
Front Oncol; 2022; 12():854151. PubMed ID: 35547880
[TBL] [Abstract][Full Text] [Related]
4. Chromatin binding by the androgen receptor in prostate cancer.
Itkonen H; Mills IG
Mol Cell Endocrinol; 2012 Sep; 360(1-2):44-51. PubMed ID: 21989426
[TBL] [Abstract][Full Text] [Related]
5. Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response.
Kukkonen K; Taavitsainen S; Huhtala L; Uusi-Makela J; Granberg KJ; Nykter M; Urbanucci A
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283056
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics in prostate cancer: clinical implications.
Conteduca V; Hess J; Yamada Y; Ku SY; Beltran H
Transl Androl Urol; 2021 Jul; 10(7):3104-3116. PubMed ID: 34430414
[TBL] [Abstract][Full Text] [Related]
7. Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer.
Deng T; Xiao Y; Dai Y; Xie L; Li X
Front Mol Biosci; 2021; 8():743376. PubMed ID: 34977151
[TBL] [Abstract][Full Text] [Related]
8. Prostate Cancer Epigenetic Plasticity and Enhancer Heterogeneity: Molecular Causes, Consequences and Clinical Implications.
Kneppers J; Bergman AM; Zwart W
Adv Exp Med Biol; 2022; 1390():255-275. PubMed ID: 36107324
[TBL] [Abstract][Full Text] [Related]
9. The epigenetic function of androgen receptor in prostate cancer progression.
Sawada T; Kanemoto Y; Kurokawa T; Kato S
Front Cell Dev Biol; 2023; 11():1083486. PubMed ID: 37025180
[TBL] [Abstract][Full Text] [Related]
10. Biological Evolution of Castration-resistant Prostate Cancer.
Davies A; Conteduca V; Zoubeidi A; Beltran H
Eur Urol Focus; 2019 Mar; 5(2):147-154. PubMed ID: 30772358
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for prostate cancer: present challenges and future opportunities.
Sharma P; Zargar-Shoshtari K; Pow-Sang JM
Future Sci OA; 2016 Mar; 2(1):FSO72. PubMed ID: 28031932
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor signaling in prostate cancer development and progression.
Lonergan PE; Tindall DJ
J Carcinog; 2011; 10():20. PubMed ID: 21886458
[TBL] [Abstract][Full Text] [Related]
13. To bind or not to bind: Cistromic reprogramming in prostate cancer.
Shen M; Demers LK; Bailey SD; Labbé DP
Front Oncol; 2022; 12():963007. PubMed ID: 36212399
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between epigenetics and tumor promoting androgen signaling in prostate cancer.
Singh VK; Kainat KM; Sharma PK
Vitam Horm; 2023; 122():253-282. PubMed ID: 36863797
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of microarray-derived genetic signatures in predicting outcomes in prostate cancer.
Reddy GK; Balk SP
Clin Genitourin Cancer; 2006 Dec; 5(3):187-9. PubMed ID: 17239271
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of prostate cancer.
Chin SP; Dickinson JL; Holloway AF
Clin Epigenetics; 2011 Aug; 2(2):151-69. PubMed ID: 22704335
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.
Simmonds P; Loomis E; Curry E
Genome Med; 2017 Jun; 9(1):54. PubMed ID: 28592290
[TBL] [Abstract][Full Text] [Related]
18. Optimizing molecular signatures for predicting prostate cancer recurrence.
Sun Y; Goodison S
Prostate; 2009 Jul; 69(10):1119-27. PubMed ID: 19343730
[TBL] [Abstract][Full Text] [Related]
19. Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer.
Zhang J; Kim S; Li L; Kemp CJ; Jiang C; Lü J
Prostate; 2020 May; 80(7):588-605. PubMed ID: 32162714
[TBL] [Abstract][Full Text] [Related]
20. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
